Denemek ALTIN - Özgür

Conference 'understanding Regulatory Perspectives Of Excipients' Hosted By Ipec

Express Pharma

|

August 16-31, 2019

Experts, manufacturers and consumers attending the conference discussed the ever-evolving regulatory framework that guides the Indian excipients industry how active communication between the suppliers and users can decrease instances of quality negligence

Conference 'understanding Regulatory Perspectives Of Excipients' Hosted By Ipec

THE INTERNATIONAL

Pharmaceutical Excipients Council (IPEC) recently organised a conference to boost communication and understanding between manufacturers and consumers involved in the supply chain for the excipients segment. Held in Mumbai, the theme of the one-day conference was 'Understanding Regulatory Perspectives of Excipients'. Speakers and experts attending the conference also discussed the ever-evolving regulatory framework that guides the Indian excipients industry and the need for Indian manufacturers to diligently adopt global GMP standards in times when they are facing stiff competition from China, USA and Europe.

Commenting on this the issue, Subodh Priolkar, Vice Chairman, IPEC India and CEO, Wincoat Colours and Coatings, spoke during his welcome address, “The Chinese Pharmacopoeia has included functional related characteristics (FRC) in a monograph which will create imbalance under the current regulatory regime. But this would definitely help excipients to perform critical functional attributes for drug safety. These are particle size, mean particle size, bulk density, viscosity, etc besides assay and chemical test. The challenge that lies in this context is that regulated markets cannot modify GMP Requirements for Certificates of Analysis (CoA) and according to Chinese regulations basis if there is a special material manufactured in China as per the local regulations. Just as if any regulated market comes out with a regulation on elemental impurities to comply with, it would be really difficult to comply when we are talking about global regulatory harmonisation.”

Express Pharma'den DAHA FAZLA HİKAYE

Express Pharma

Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

time to read

9 mins

January 2026

Express Pharma

Express Pharma

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

time to read

2 mins

January 2026

Express Pharma

Express Pharma

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

time to read

1 mins

January 2026

Express Pharma

Express Pharma

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

time to read

3 mins

January 2026

Express Pharma

Express Pharma

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

time to read

3 mins

January 2026

Express Pharma

Express Pharma

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

time to read

8 mins

January 2026

Express Pharma

Express Pharma

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

time to read

5 mins

January 2026

Express Pharma

Express Pharma

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

time to read

5 mins

January 2026

Translate

Share

-
+

Change font size